Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tert-butyl [(2-amino‐4‐oxo‐4,7‐dihydro‐3H‐pyrrolo[2,3‐d]pyrimidin‐5‐yl)methyl]carbamate is a synthetic small molecule belonging to the pyrrolopyrimidine class. It is an experimental compound with no approved medical indications or known clinical development as of June 2025. The compound has been referenced in chemical and drug databases but lacks detailed information on its mechanism of action or therapeutic use. Its structure suggests it may be a derivative or intermediate related to nucleoside analogs or antifolate agents; however specific pharmacological activity has not been established in public sources[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate.